Cansino Biologics Stock Filter Stocks by Fundamentals
CASBF Stock | USD 3.90 0.00 0.00% |
CanSino Biologics fundamentals help investors to digest information that contributes to CanSino Biologics' financial success or failures. It also enables traders to predict the movement of CanSino Pink Sheet. The fundamental analysis module provides a way to measure CanSino Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CanSino Biologics pink sheet.
CanSino |
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
All Next | Launch Module |
CanSino Fundamentals
Return On Equity | 0.0111 | |||
Return On Asset | -0.0207 | |||
Profit Margin | 0.06 % | |||
Operating Margin | (0.19) % | |||
Current Valuation | 3.58 B | |||
Shares Outstanding | 114.78 M | |||
Shares Owned By Insiders | 26.70 % | |||
Shares Owned By Institutions | 38.17 % | |||
Price To Earning | 19.25 X | |||
Price To Book | 2.30 X | |||
Price To Sales | 2.51 X | |||
Revenue | 4.3 B | |||
Gross Profit | 3 B | |||
EBITDA | 2.05 B | |||
Net Income | 1.91 B | |||
Cash And Equivalents | 7 B | |||
Cash Per Share | 28.36 X | |||
Total Debt | 40 M | |||
Debt To Equity | 0.26 % | |||
Current Ratio | 2.99 X | |||
Book Value Per Share | 29.22 X | |||
Cash Flow From Operations | 2.05 B | |||
Earnings Per Share | 0.59 X | |||
Number Of Employees | 1.95 K | |||
Beta | 0.61 | |||
Market Capitalization | 3.15 B | |||
Total Asset | 11.87 B | |||
Z Score | 46.8 | |||
Annual Yield | 0.01 % | |||
Net Asset | 11.87 B | |||
Last Dividend Paid | 0.8 |
About CanSino Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CanSino Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CanSino Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CanSino Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CanSino Pink Sheet
CanSino Biologics financial ratios help investors to determine whether CanSino Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanSino with respect to the benefits of owning CanSino Biologics security.